Reckitt Benckiser Group Plc (LON:RKT) reported underlying revenue of £12.9bn, excluding the sold Chinese Infant Nutrition business (IFCN China). This was up 3.3% on a constant currency, like-for-like basis (LFL) and was ahead of expectations. Performance was driven by improved pricing and sales mix, though volumes also rose slightly. Q4 2021 hedge fund letters, conferences and more Excluding IFCN China, underlying operating profits fell 2.6% to £2.9bn. That was largely due to cost inflation in the region of 11%. The group’s targeting LFL revenue growth between 1-4% for 2022. Despite CEO Laxman…